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Background: The mechanisms responsible for cervical cancer radioresistance are still largely unexplored. The
present study aimed to identify miRNAs associated with radioresistance of cervical cancer cells.
Methods: The radioresistant cervical cancer cell variants were established by repeated selection with irradiation.
The miRNA profiles of radioresistant cells and their corresponding controls were analyzed and compared using
microarray. Differentially expressed miRNAs were confirmed by quantitative real-time PCR. Cervical cancer cells were
transfected with miRNA-specific mimics or inhibitors. Radiosensitivity of cervical cancer cells were determined using
colony-forming assay.
Results: Among the differentially expressed miRNAs, 20 miRNAs showed the similar pattern of alteration (14 miRNAs
were overexpressed whilst 6 were suppressed) in all three radioresistant cervical cancer cell variants compared to their
controls. A miRNA signature consisting of 4 miRNAs (miR-630, miR-1246, miR-1290 and miR-3138) exhibited more than
5 folds of increase in radioresistant cells. Subsequent analysis revealed that these four miRNAs could be up-regulated in
cervical cancer cells by radiation treatment in both time-dependent and dose-dependent manners. Ectopic expression
of each of these 4 miRNAs can dramatically increase the survival fraction of irradiated cervical cancer cells. Moreover,
inhibition of miR-630, one miRNA of the specific signature, could reverse radioresistance of cervical cancer cells.
Conclusions: The present study indicated that miRNA is involved in radioresistance of human cervical cancer cells and
that a specific miRNA signature consisting of miR-630, miR-1246, miR-1290 and miR-3138 could promote radioresistance
of cervical cancer cells.
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Cervical cancer is the second largest cause of cancer mor-
tality in women worldwide with more than 270 000 deaths
per year [1]. Radiotherapy has a significant role in defini-
tive and adjuvant therapy for cervical cancer. Investiga-
tions showed that radiotherapy is used to treat more than
60% of cervical cancer cases [2]. Unfortunately, studies
also indicated that the overall incidence of local recur-
rence is 13% following definitive radiotherapy [3], which
suggesting that recurrence after radiotherapy remains a
problem in the treatment of cervical cancer. The major
obstacle to the treatment success of radiotherapy is* Correspondence: yrendq@fmmu.edu.cn; junyeliu@fmmu.edu.cn
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reproduction in any medium, provided the orradioresistance. Moreover, salvaging previously radioresis-
tant tumors using either radiotherapy or surgery with con-
cern for normal tissue complications is difficult. Therefore,
it has significance to reveal the mechanisms underlying
radioresistance in cervical cancer.
Some progress has been achieved in the past decades.
Increased DNA repair of cancer cells [4] and hypoxia in
tumor microenvironment [5,6] have been proposed to
be the major reasons for radioresistance. In addition,
EGFR [7,8], Cox-2 [9,10], AKT [11], and Her-2 [12]
were also suggested playing some roles in radioresis-
tance in cervical cancer in different ways. However,
mechanisms responsible for cervical cancer radioresis-
tance are still largely unexplored.
MicroRNAs (miRNAs) are noncoding RNAs of approxi-
mate 22 nt in length that function as post-transcriptionalLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Three radioresistant cervical cancer cell variants were
established. The radioresistant variants Hela-R11 (A) and Siha-R15 (B)
were established by exposing Hela and Siha cells to 11 and 15 cycles
of sequential radiation, respectively. Another radioresistant cervical
cancer cells Hela-NDRG2 (C) and their control Hela-C cells were
generated in our previous study by transfection with constructs
expressing NDRG2 and control vector respectively in Hela cells. The
cervical cancer cells were exposed to irradiation at indicated dosage
and survival fractions were determined by colony-forming assay as
described in “Materials and methods”. Data was expressed as mean ±
SD of triplicates in one experiment. Shown was representative of at
least 3 experiments.
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in the 3′-untranslated region (3′UTR) of the mRNA, miR-
NAs control mRNA stability and translation efficiency
[13-15]. Considering that miRNAs are predicted to regu-
late translation of a lot of human mRNAs [16], it is no sur-
prise that miRNAs have emerged as important regulators
in developmental, physiological and pathological settings
including cell growth, differentiation, apoptosis, metabol-
ism and tumorigenesis [17]. More recently, several miR-
NAs have been demonstrated to be involved in tumor
radioresistance. MiR-210 [18], miR-17-92 [19], miR-31 [20],
miR-221 and miR-222 [21] have been documented to be
dysregulated in radioresistant cancer cells and to promote
cancer radioresistance. However, little is known concerning
the role of miRNAs in cervical cancer radioresistance.
Driven by these observations, we decided to investi-
gate whether miRNAs play a role in the radioresistance
of cervical cancer. We started the present study from
establishment of radioresistant cervical cancer cell vari-
ants, Hela-R11 and Siha-R15, by repeated selection of
Hela and Siha cells with low-dosage of radiation. In the
previous study, we have demonstrated that N-Myc
downstream-regulated gene 2 (NDRG2) could promote
radioresistance of cervical cancer Hela cells [22]. The
radioresistant cells Hela-NDRG2 and their control Hela-C
cells were also used in this study, which were previously
generated by transfection with constructs expressing
NDRG2 and control vector respectively in Hela cells [22].
The miRNA profiles of Hela-R11/Hela, Siha-R15/Siha and
Hela-NDRG2/Hela-C cells were analyzed with miRNA
microarray. A specific miRNA signature was revealed as-
sociated with radioresistance of human cervical cancer
cells.
Results
Establishment of radioresistant cervical cancer cell variants
Prior to the analysis of miRNA expression, we first estab-
lished three couples of human cervical cancer cell lines.
One of each couple is radioresistant while another is ra-
diosensitive. The radioresistant Hela-R11 and Siha-R15
cells were derived from their radiosensitive parent cells
Hela and Siha by repeated selection with radiation, re-
spectively. Briefly, at the very beginning, the Hela and Siha
cells were exposed to 2 Gy of irradiation, which leads to
apoptosis of the majority of cells. The rest viable cells were
subcultured and expanded in the next 3–5 days. The radi-
ation treatment was repeated when cells reach 60-90%
confluency. The apoptosis barely appeared in Hela-R11
and Siha-R15 cells after 11 and 15 cycles of screening, re-
spectively. This result suggested that these two sublines
achieved radioresistance. Moreover, we have demonstrated
in our previous study that the Hela-NDRG2 cells were
radioresistant when compared to Hela-C cells [22]. This
couple of cells was generated by transfection withconstructs expressing NDRG2 and control vector respect-
ively in Hela cells. In the next step, clonogenic assay
was performed to examine the cell survival fractions to
further demonstrate the significant differences between
radioresistant and control cervical cancer cells. It was
shown that the cell survival fractions of Hela-R11,
Siha-R15 and Hela-NDRG2 cells were strikingly in-
creased when compared to Hela, Siha and Hela-C cells
as their controls respectively (Figure 1). These results
indicated that Hela-R11, Siha-R15 and Hela-NDRG2
cell lines were successfully established as the radioresis-
tant cervical cancer cell variants.
Each of these three couple of cells have same origin but
with distinctly different radiosensitivities, providing us
models to investigate the molecular determinants of
Figure 2 Human radioresistant cervical cancer cells displayed
differential miRNA profiles. The miRNA profiles of cervical cancer
cells were analyzed with miRNA microarray. The profiles of
radioresistant cells (Hela-NDRG2, Hela-R11 and Siha-R15) were
compared to their corresponding controls (Hela-C, Hela and Siha).
Schematic map showed the number of miRNAs with more than 2
folds changes of expression in radioresistant cells (red number
denotes up-regulated miRNAs while green number denotes
down-regulated miRNAs). The differential miRNA profiles shared by
those radioresistant cells were indicated.
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the number of confounding factors, such as inherent gen-
etic variation, that may arise when using cell lines of dif-
ferent origin.
miRNA profile associated with radioresistance of human
cervical cancer cells
To investigate the radio-specific changes in the micro-
RNAome of radioresistant cervical cancer cells, we assessed
the global miRNA expression profile of above three couple
of cells by microarray technology. The miRNA expression
profile showed that the differences of miRNA expression
between radioresistant and radiosensitive human cervical
cancer cells were extremely intricate. There were 88, 105
and 102 kinds of miRNAs overexpressed whilst 47, 64
and 56 were suppressed in Hela-NDRG2, Hela-R11 and
Siha-R15 cells when compared to Hela-C, Hela and Siha
cells as their control respectively. However, it should be
noted that there were only 20 miRNAs, of which 14 were
up-regulated and others were down-regulated, having the
similar alteration in all three radioresistant cervical cancer
cell variants compared to their control (Figure 2). More-
over, quantitative real-time PCR (qRT-PCR) assays have
been performed in above three couple of cells to determine
the expression change of these 20 miRNAs. The results of
qRT-PCR were exactly in consistent with microarray that
14 miRNAs were overexpressed whilst 6 were suppressed
in all three radioresistant cervical cancer cell variants com-
pared to their control (Figure 3). These data suggested that
miRNA profile was associated with radioresistance of hu-
man cervical cancer cells.
Specific miRNA signature is increased upon exposure to
radiation in human cervical cancer cells
Of note, qRT-PCR illustrated that the expression of 4 miR-
NAs were up-regulated over 5 folds, including miR-630,
miR-1246, miR-1290 and miR-3138. Nevertheless, there
were no such significant differences in expressions of
other miRNAs (Figure 3). Hence, we selected this specific
miRNA signature for further investigation. To find out
whether radiation could regulate the expression of this
specific miRNA signature, we first analyzed the expression
of miR-630, miR-1246, miR-1290 and miR-3138 by qRT-
PCR in human cervical cancer Hela cells after radiation at
a dose of 6 Gy. It was shown that the expression of all
these 4 miRNAs was increased upon exposure to radiation
in a time dependent manner and sustained at least for
24 h. While the specific miRNA signature expression
hasn’t significantly influenced by 2 h of radiation treat-
ment, it was apparently elevated 4 h after radiation, stead-
ily increased to its peak at 12 h and then gradually
decreased (Figure 4A). In another set of experiment, Hela
cells were irradiated at different dosage and the specific
miRNA signature expression was followed 12 h afterradiation. It was clear that the expression of these 4 miR-
NAs could be also up-regulated by radiation in a dose
dependent manner. Moreover, 6 Gy of radiation showed
the most profound effects on up-regulation of the specific
miRNA signature expression, even though all those dos-
ages of radiation had stimulating effects (Figure 4B). The
extremely similar results were observed in human cervical
cancer Siha cells (data not shown). The above results re-
vealed that this specific miRNA signature is increased
upon exposure to radiation in human cervical cancer cells
in both time dependent and dose dependent manners,
suggesting a potential role of this miRNA signature in
radioresistance of cervical cancer cells.
Specific miRNA signature promotes radioresistance of
human cervical cancer cells
To investigate whether the specific miRNA signature is in-
volved in the development of radioresistance of cervical
cancer cells, we used Hela cells transfected with the
mimics specific for the 4 miRNAs, which respectively ex-
press relatively higher miR-630, miR-1246, miR-1290 and
miR-3138 than negative control cells (data not shown).
After exposure to 0, 2, 4, 6, 8, 10 Gy of irradiation respect-
ively, cell survival fractions were examined using a
Figure 3 Twenty miRNAs were differentially expressed in radioresistant cervical cancer cell variants. Quantitative real-time PCR was
performed to determine the expression levels of 14 up-regulated (A) and 6 down-regulated (B) miRNAs in cervical cancer cells. Data was expressed as fold
change of radioresistant variants comparing to their corresponding controls. Shown was representative of 3 independent experiments.
Figure 4 Radiation induced expression of a miRNA signature in cervical cancer cells in time-dependent and dose-dependent manners.
Hela cells were exposed to irradiation at 6 Gy for desired time (A) or at indicated dosage for 12 h (B). The expression levels of miRNAs were
evaluated using quantitative real-time PCR. Fold changes of irradiated cells comparing to non-irradiated controls were calculated. Data was expressed
as mean ± SD of triplicates in one experiment. Shown was representative of 3 independent experiments. *p < 0.05 vs non-irradiated controls.
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signature on radiosensitivity. It was shown that overexpres-
sion of each of these 4 miRNAs by transfection with their
mimic can dramatically increased the survival fraction of
irradiated Hela cells (Figure 5A). The results obtained from
Siha cells (Figure 5B), which subject to the same treatment,
were in accordance with the above results. We noted that
the radiosensitivities of Hela and Siha cells transfected with
miR-630-mimics were much more significantly attenuated
when compared to cells transfected with other miRNAs in
the specific miRNA signature (Figure 5A,B). Therefore, the
miR-630 was selected for the further experiments as the
symbol of the specific miRNA signature. The expression of
miR-630 in Hela-NDRG2, Hela-R11 and Siha-R15 cells
was suppressed by transfection with miR-630-inhibitors
(data not shown). As indicated by the results of clonogenic
assay, significantly lower survival fractions were noted in
cervical cancer cells with suppressed miR-630 when com-
pared to their controls (Figure 6A,B,C). These suggested
that inhibition of miR-630, delegate of the specific miRNA
signature, could reverse radioresistance of cervical cancer
cells. Taken together, it was indicated that this specific
miRNA signature could promotes radioresistance of hu-
man cervical cancer cells.Figure 5 Specific miRNA signature promoted radioresistance of
human cervical cancer cells. Hela (A) or Siha (B) cells were
transfected with specific miRNA mimics and exposed to irradiation
at indicated dosage. The survival fractions were determined by
colony-forming assay as described in “Materials and methods”. Data
was expressed as mean ± SD of triplicates in one experiment. Shown
was representative of 3 independent experiments.Discussion
Impaired responsiveness of tumors to radiotherapy is a
major clinical problem in cervical cancer. Although exten-
sive studies have been carried out to reveal the mecha-
nisms underlying radioresistance, evidences so far suggest
that mechanisms responsible for cervical cancer radiore-
sistance are still not clear and likely to be intricate. Our
present data indicated that a specific miRNA signature
including miR-630, miR-1246, miR-1290 and miR-3138
could promote radioresistance of human cervical cancer
cells. This is the first study suggesting the involvement of
miRNAs in the cervical cancer radioresistance, to our
knowledge.
miRNAs have been demonstrated to be regulators of
many functional genes. It has been shown miR-218 couldFigure 6 Inhibition of miR-630 increased radiosensitivity of
cervical cancer cells. The radioresistant cervical cancer cell variants,
including Hela-NDRG2 (A), Hela-R11 (B) and Siha-R15 (C), were
transfected with miR-630 specific inhibitors (630-I) and exposed to
irradiation. The survival fractions were determined by colony-forming
assay as described in “Materials and methods”. Data was expressed as
mean ± SD of triplicates in one experiment. Shown was representative
of 3 independent experiments.
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focal adhesion pathway [23], impair tumor growth and in-
crease chemo-sensitivity to cisplatin through regulating
the AKT-mTOR signaling pathway [24] and suppress pro-
gression through downregulation of survivin and the
SLIT2-ROBO1 pathway [25]. miRNA microarray analysis
has been performed to compare the differences of miRNA
profiles between cervical cancer tissues and normal cer-
vical tissues [26,27] or adjacent normal cervical tissues
[28], suggesting important roles of specific miRNAs in cer-
vical tumorigenesis. However, miRNA function depends
on the particular tissue type in which they are found and
the cellular environment in which they are expressed [29].
In the present study, miRNA microarray was employed to
compare the miRNA profiles of 3 couples of cervical can-
cer cell variants derived from different origin, of which
one is radioresistant and another is the corresponding
control. This strategy helps us to omit the prior influence
of tissue type and cellular environment on miRNA expres-
sion pattern and clarify the mechanisms of human cervical
cancer radioresistance in a way. Although altered expres-
sion of vast miRNAs in radioresistant cervical cancer cell
models was indicated, only a limited miRNA profile, that
contains 14 miRNAs which were up-regulated and 6
others suppressed, has been shared by all three radioresis-
tant cell variants. Hela-NDRG2 and Hela-R11, deriving
from the same cell line, have 31 miRNAs overlapped. This
may reflect different influence of generation methods on
miRNA expressing profiles. Hela-NDRG2 was generated
by overexpressing NDRG2 in Hela cells, while Hela-R11
was established by repeated exposure to radiation for 11
times. On the other hand, the overlapped miRNAs have
the bigger possibility to be the drivers while other miRNAs
may be passengers in responding to radiation. These
strongly indicate that some miRNAs are specific to and in-
volved in radioresistance of cervical cancer cells.
Several miRNAs have been demonstrated to be in-
volved in radioresistance as suppressors. miR-210 [18],
miR-17-92 [19], miR-31 [20], miR-221 and miR-222 [21]
have been documented to be down-regulated in radiore-
sistant cancer cells, to regulate the expression of AIFM3,
MNT and PTEN respectively, and to promote cancer
radioresistance. In the present study, 4 miRNAs (miR-
630, miR-1246, miR-1290 and miR-3138) showing more
than 5 folds of expression changes were selected for fur-
ther analysis. This specific miRNA signature is increased
upon exposure to radiation in human cervical cancer
cells in a time dependent and a dose dependent man-
ners. Most recently, Chaudhry et al. [30] reported the
identification of radiation-induced miRNA transcrip-
tome by next-generation massively parallel sequencing
in human lymphoblast cell TK6. It was shown that more
than 30 miRNAs are modulated by irradiation. Interest-
ingly, 12 miRNAs exhibited two peaks of induction while15 miRNAs were induced only at one time point [30]. In
another study, the same group analyzed radiation-induced
miRNA modulation in glioblastoma cells M059J and
M059K, two cell lines from the same origin. M059J is defi-
cient in DNA-dependent protein kinase whereas M059K
has normal kinase activity. The miR-17-3p, miR-17-5p,
miR-19a, miR-19b, miR-142-3p, and miR-142-5p were up-
regulated in both M059K and M059J cells [31]. However,
the miR-15a, miR-16, miR-143, miR-155, and miR-21 were
upregulated in M059K, and the modulation of these miR-
NAs fluctuated in M059J cells in a time-dependent man-
ner [31]. The dynamic miRNA profiles in M059 cells are
different from that in TK6 cells. The radiation-induced
miRNAs (miR-630, miR-1246, miR-1290 and miR-3138)
in cervical cancer cells are not included in the miRNA
profiles of M059 and TK6, supporting the speculation that
the modulation of miRNA is dependent on cell type, radi-
ation dose and dose rate [30].
The present study also demonstrated that overexpres-
sion of the specific miRNA signature (miR-630, miR-
1246, miR-1290 and miR-3138) by transfection with its
mimics respectively could enhance the radioresistance
in cervical cancer cells, and that suppression of miR-
630, delegate of the specific miRNA signature, attenu-
ates the radioresistance in cervical cancer cells. These
results suggest that overexpression of this specific
miRNA signature may be important for surviving the
cytotoxic effects of radiation and promotes radioresis-
tance of human cervical cancer cells. It has been re-
ported that miR-630 regulates cisplatin-induced cancer
cell death [32] and acts as a regulator downstream of
phospho-ΔNp63α in autophagy [33]. miR-1246 can be
up-regulated in human epidermoid carcinoma cells
A431 in response to photodynamic therapy [34], serve
as a novel diagnostic and prognostic biomarker for
oesophageal squamous cell carcinoma [35] and multiple
myeloma [36]. Up-regulation of microRNA-1290 impairs
cytokinesis and affects the reprogramming of colon cancer
cells [37]. The present study reveals positive roles of miR-
630, miR-1246, miR-1290 and miR-3138 in radioresistance
of cervical cancer cells, supporting regulatory roles of
miRNAs in radioresistance. However, it should be noted
that the targets of these miRNAs and the relative pathways
need further exploration.
Conclusions
In conclusion, our findings suggest that miRNAs may play
a role in radioresistance of cervical cancer and a specific
miRNA signature promotes radioresistance of human cer-
vical cancer cells. These data can help us to better under-
stand the molecular mechanisms underlying resistance to
radiation and the role of miRNAs in development of can-
cer radioresistance. Further studies are encouraged to re-
veal the targets and mechanisms underlying the specific
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clinical relevance and significance of this specific miRNA
signature in cervical cancer.
Materials and methods
Cell culture and transfection
The human cervical cancer cell lines Hela and Siha were
obtained from the American Type Culture Collection
(Manassas, VA). Hela variants Hela-NDRG2 and Hela-C
were previously established by stable transfection with con-
structs expressing NDRG2 and control vector respectively
in Hela cells [22]. All the cells were maintained as a mono-
layer in Dulbecco’s modified Eagle’s medium (Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum
(Sijiqing Biological Engineering Materials Co., Hangzhou,
China) at 37°C in the presence of 5% CO2-balanced air.
The mimics and inhibitors specific for miR-630, miR-
1246, miR-1290 and miR-3138 were obtained from
Ambion (Grand Island, NY). Cervical cancer cells were
transfected with the miRNA mimics or inhibitors at a final
concentration of 100 μM (mimics) or 200 μM (inhibitor)
using LipofectamineTM 2000 (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instruction.
Irradiation
Irradiation was performed using a 60Co γ-ray therapeutic
machine, RCR-120 (Toshiba, Tokyo, Japan), at a dose
rate of 1.6 Gy/min.
Colony-forming assay
The radiosensitivity of cervical cells was determined using
colony-forming assay as previously described [22]. In brief,
cancer cells at 60-80% confluency were trypsinized into
single cell suspension and exposed to desired dosage of
irradiation. Following exposure, cells (200–2000) were
plated in 60 mm dishes and incubated at 37°C, 5% CO2
for colony formation. After 10–14 days of growth, the col-
onies were fixed with 10% (v/v) methanol for 15 min and
stained with 5% (g/v) Giemsa solution (Sigma) for 20 min.
Colonies that consisted of more than 50 cells were scored.
Colony plating efficiency was calculated to be the number
of viable plated cells, and expressed as a percentage of in-
oculated cells. In each group, survival fraction of cells was
calculated as plating efficiency of the irradiated cells di-
vided by the plating efficiency of the untreated control.
Survival curves were plotted as the log of survival fraction
versus radiation dosage.
miRNA microarray analysis
The miRNA profiles of three couple of cells (Hela-R11/
Hela, Siha-R15/Siha and Hela-NDRG2/Hela-C) were ana-
lyzed using miRNA microarray. Total RNA from cervical
cancer cells was isolated with Trizol reagent (Invitrogen,
Carlsbad, CA) and miRNA fraction was further purifiedusing a mirVanaTM miRNA isolation kit (Ambion, Austin,
TX). The isolated miRNAs from the 2 cell lines of each
couple were then labeled with Hy3 using the miRCUR-
YTM Array Labelling kit (Exiqon, Vedbaek Denmark) and
hybridized respectively on a miRCURYTM LNA micro-
RNA Array (v 8.0, Exiqon) as described [38]. Microarray
images were acquired using a Genepix 4000B scanner
(Axon Instruments, Union City, CA) and processed and
analyzed with Genepix Pro 6.0 software (Axon Instru-
ments) and Excel.
Real-time PCR
The expression levels of miRNAs in cervical cancer cells
were determined using real-time PCR. Total RNA of cer-
vical cancer cells was extracted using Trizol reagent (Invi-
trogen, Carlsbad, CA) and reverse transcription was
performed according to the manufacturer’s instructions
(D350A, TaKaRa Biotechnology, Dalian, Liaoning, China).
Quantitative real-time PCR (qRT-PCR) was performed to
determine the expression levels of each miRNA using the
exact sequences (U to T) of these miRNAs as the forward
primer and the unique q-PCR primer from the cDNA
Synthesis Kit. U6 was used as an internal control, and each
plate contains one cDNA sample for each primer as a cor-
rect sample.
Statistical analysis
Data are expressed as mean ± SD. Statistical analyses were
performed with the SPSS software (version 10.0; SPSS,
Chicago, IL) by using one-way ANOVA followed by the t-
test for independent groups. A p level of < 0.05 was con-
sidered statistically significant.
Abbreviations
miRNA: microRNA; NDRG2: N-Myc downstream-regulated gene 2;
qRT-PCR: Quantitative real-time PCR.
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